We read with interest the article of Dempsey and Barrington, 1 as well as the accompanying editorial of Raab and Seri 2 describing the diagnosis and treatment of the hypotensive, very low birth weight infant during postnatal transitions. The discussion of the diagnostic criteria for hypotension is well presented and highly informative, although our comments relate to the discussion of therapeutic interventions. We have witnessed resuscitations of both preterm and term infants with difficult neonatal transitions and appropriately, the neonatal service focuses on treatment of the most common etiologies of infection or asphyxia. On occasion, severe, acute fetal anemia accounts for the need for resuscitation and accompanied hypotension. Hemorrhage may result from acute fetal to maternal transfusion, placental abruption (occasional fetal vessel bleed), vasoprevia or subgaleal hemorrhage. As these babies may present with an abnormal fetal heart tracing and/or evidence of asphyxia, in the absence of visible hemorrhage, the management often focuses on ventilatory support, antibiotic prophylaxis and pressor therapy.
Although blood pressure determinations are generally not made in the delivery room, attempts at improved perfusion commonly include the interventions discussed in the manuscripts (volume expansion, inotropic support and corticosteroids). Often times, newborn hematocrit values are not obtained until stabilization in the nursery. This hematocrit, however, may demonstrate a value in the low-normal range, which can be interpreted as a dilutional response to volume therapy, rather than as progression of an intrapartum/neonatal bleed. It is only with subsequent hematocrit values below the normal range, that it is recognized that the initial 'low-normal' value was in fact a progression from normal to critical. In many, if not most cases of compromised newborns, umbilical cord blood gases are obtained. However, these values typically do not include hematocrit or hemoglobin assessment.
In view of the contribution of intrapartum/neonatal hemorrhage to newborns in need of resuscitation, we would suggest that obstetric and neonatal services consider the measurement of umbilical cord hemoglobin/hematocrit values in all cases of compromised newborns. An assessment of this value would facilitate the recognition of a recent hemorrhagic event, as well as provide a baseline value which can be compared to the subsequent neonatal value, for early evidence of a downward trend. 
MG Ross

Response to Drs Ross and Smith
Journal of Perinatology (2007 Perinatology ( ) 27, 325-326. doi:10.1038 Thank you for your interest in the recent publications. Our survey study was aimed at determining the approach to hypotension in preterm infants among neonatologists and we did not specifically ask the respondents whether assessment for, or treatment of, concealed hemorrhage was part of the therapeutic algorithms they followed. Drs Ross and Smith are probably correct that in preterm infants with hypotension have hidden blood loss, and specifically that feto-maternal hemorrhage is not near the top of the list of differential diagnoses. Indeed after searching the literature the incidence of significant feto-maternal hemorrhage in infants delivering preterm is unknown. Although measurement of cord blood hematocrit or hemoglobin in compromised newborns sounds sensible, I am unaware of any prospective studies to demonstrate that this is truly useful or improves management. Such data would be very useful to guide future practice.
K Barrington
